These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 7074649)

  • 41. Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease.
    Zittoun R; Audebert A; Hoerni B; Bernadou A; Krulik M; Rojouan J; Eghbali H; Merle-Béral H; Parlier Y; Diebold J
    J Clin Oncol; 1985 Feb; 3(2):207-14. PubMed ID: 3838188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intensive chemotherapy for Hodgkin's disease: long-term complications.
    DeVita VT; Arseneau JC; Sherins RJ; Canellos GP; Young RC
    Natl Cancer Inst Monogr; 1973 May; 36():447-54. PubMed ID: 4744600
    [No Abstract]   [Full Text] [Related]  

  • 43. [The management of Hodgkin's disease with chemotherapy or combined modality treatment].
    Tsushita K; Utsumi M; Shimoyama M
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2202-9. PubMed ID: 9881076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The cure of disseminated Hodgkin's disease: prospects and problems.
    Streuli RA; Ultmann JE
    Ann Intern Med; 1980 May; 92(5):693-5. PubMed ID: 7387012
    [No Abstract]   [Full Text] [Related]  

  • 45. Protection from chemotherapeutic epilation by prior irradiation.
    Cassady JR; Jaffe N
    Radiology; 1974 Jul; 112(1):197-8. PubMed ID: 4832493
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of lower torso stages I and II Hodgkin's disease with radiation with or without adjuvant mechlorethamine, vincristine, procarbazine, and prednisone.
    Givens SS; Fuller LM; Hagemeister FB; Gehan EA
    Cancer; 1990 Jul; 66(1):69-74. PubMed ID: 2354411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An evaluation of total nodal irradiation as treatment for stage III A Hodgkin's disease.
    Mauch P; Goodman R; Rosenthal DS; Botnick L; Piro AJ; Hellman S
    Cancer; 1979 Apr; 43(4):1255-61. PubMed ID: 445328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A trial of applying an oily suspension of bleomycin endolymphatically in patients with Hodgkin's disease of the extraperitoneal lymph nodes].
    Ziółko E
    Pol Merkur Lekarski; 1997 Jul; 3(13):8-9. PubMed ID: 9432303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Use of risk-adapted programs of treatment of Hodgkin's disease in children and adolescents].
    Kuleva SA
    Vopr Onkol; 2008; 54(6):768-70. PubMed ID: 19241857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Multiple drug treatment of Hodgkin's disease: the MOPP schedule].
    Singer Z; Dzieza-Lalowicz I; Kardaszewicz S; Rozek-Lesiak K
    Nowotwory; 1978; 28(2):203-8. PubMed ID: 683884
    [No Abstract]   [Full Text] [Related]  

  • 51. Radiotherapy of stage I and II Hodgkin disease with inguinal presentation.
    Lanzillo JH; Moylan DJ; Mohiuddin M; Kramer S
    Radiology; 1985 Jan; 154(1):213-5. PubMed ID: 3838078
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Second malignant tumours in childhood Hodgkin's disease.
    Jenkin D; Greenberg M; Fitzgerald A
    Med Pediatr Oncol; 1996 Jun; 26(6):373-9. PubMed ID: 8614372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Status and perspectives in chemotherapy of Hodgkin's disease.
    Frei E
    Arch Intern Med; 1973 Mar; 131(3):439-45. PubMed ID: 4739436
    [No Abstract]   [Full Text] [Related]  

  • 54. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Supradiaphragmatic Hodgkin's disease: is there a role for MOPP chemotherapy in patients with bulky mediastinal disease?
    Mauch P; Hellman S
    Int J Radiat Oncol Biol Phys; 1980 Jul; 6(7):947-9. PubMed ID: 7204134
    [No Abstract]   [Full Text] [Related]  

  • 57. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
    Hudson MM; Krasin M; Link MP; Donaldson SS; Billups C; Merchant TE; Kun L; Billet AL; Kaste S; Tarbell NJ; Howard S; Friedmann AM; Hurwitz CA; Young JA; Marcus KC; Rai S; Cowan T; Weinstein HJ
    J Clin Oncol; 2004 Nov; 22(22):4541-50. PubMed ID: 15542805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extrapyramidal tract syndrome following intensive MOPP therapy for stage IV-B Hodgkin's disease in childhood.
    Sinniah D; Lin HP
    Cancer; 1979 May; 43(5):1587-9. PubMed ID: 445354
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The chemotherapeutic treatment of advanced Hodgkin's disease].
    Epelbaum R; Haim N; Ben-Shahar M; Valtuch I; Faraggi D; Sharabi-Nov A; Ben-Arie Y; Cohen Y
    Harefuah; 2001 Apr; 140(4):311-5, 367. PubMed ID: 11303395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The management of Hodgkin's disease.
    Constable W; Leavell BS
    Va Med Mon (1918); 1970 Jun; 97(6):381-7. PubMed ID: 5006092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.